German-based speciality pharmaceutical and surgical company Croma Pharma and Ruck Tmed have entered into a partnership to develop and market a new generation of ophthalmology surgery systems.

The partnership will focus on phacoemulisification and vitrectomy surgical systems, developed by Ruck Tmed.

Ruck Tmed will market the ophthalmology surgery systems in Germany, Switzerland and the Benelux, while Croma Pharma will supply to all other markets worldwide.

Croma managing director Andreas Prinz said the combination of Ruck’sesign and development with Croma’s extensive distribution network will generate synergistic advances for ophthalmic surgeons worldwide.